TỶ LỆ VÀ MỘT SỐ YẾU TỐ LIÊN QUAN ĐẾN TĂNG ÁP LỰC ĐỘNG MẠCH PHỔI TRONG BỆNH THẬN MẠN GIAI ĐOẠN 5

Abstract

Background: Chronic kidney disease stage 5 is characterized by irreversible decline in kidney function, leading to numerous serious complications, notably pulmonary arterial hypertension. This condition is often undiagnosed in a timely manner but is closely associated with high mortality rates due to cardiovascular and pulmonary complications. Identifying related factors and early detection are crucial. However, in Vietnam, research on this issue remains limited, presenting significant challenges in effective management and treatment. Objectives: To determine the prevalence and analyze various factors associated with pulmonary hypertension in patients with end-stage renal disease. Materials and methods: A cross-sectional descriptive study conducted on 74 patients with chronic kidney disease stage 5 undergoing regular hemodialysis at the Nephrology and Dialysis Department of Kien Giang Provincial General Hospital from June 2023 to March 2024. Results: The average age was 49.85 ± 11.95, with females accounting for 63.5%. 39.2% of end-stage chronic kidney disease patients undergoing regular dialysis had pulmonary arterial hypertension. Most had moderate pulmonary alterial hypertension (82.7%). Fluid overload, hypertension, anemia, a dialysis duration of over 5 years, and type 2 diabetes are factors that increase the incidence of pulmonary alterial hypertension. Conclusion: Pulmonary arterial hypertension is common in patients with end-stage renal disease undergoing hemodialysis. Most cases are of moderate severity. Fluid overload, hypertension, anemia, a dialysis duration of over 5 years, and type 2 diabetes are factors that increase the incidence of pulmonary alterial hypertension.